Company Filing History:
Years Active: 2000
Title: Jaroslava Novotny: Innovator in Vaccine Development
Introduction
Jaroslava Novotny is a prominent inventor based in the United States, known for her significant contributions to the field of vaccine development. With a focus on antigenic preparations, her work has the potential to impact public health positively.
Latest Patents
Jaroslava holds a patent for "Antigenic preparations and the isolation of such preparations." This invention provides a vaccine containing a proteinaceous material derived from the outer membrane of Bordetella pertussis. The proteinaceous material is characterized by a relative molecular weight of about 67,000 to 73,000, preferably 69,000, as determined by 12% (w/w) polyacrylamide gel electrophoresis. Additionally, it has a proline:glutamic acid ratio of about 1:1, as determined by amino acid analysis, in a pharmaceutically acceptable carrier or adjuvant. The invention also outlines a method of inducing an immune response in an individual by administering the vaccine.
Career Highlights
Jaroslava is associated with Medeva Pharma Limited, where she continues to advance her research and development efforts in the pharmaceutical industry. Her innovative approach to vaccine formulation showcases her dedication to improving health outcomes.
Collaborations
Some of her notable coworkers include Pavel Novotny and Juan Antonio Crespo, who contribute to her research endeavors.
Conclusion
Jaroslava Novotny's work in vaccine development exemplifies the critical role of inventors in advancing medical science. Her patent on antigenic preparations highlights her innovative spirit and commitment to public health.